"Any fool can make a rule and any fool will mind it"

BMC Medicine

Volumn 14, Issue 1, 2016, Pages

  Wells, Athol U ^a  

^a ROYAL BROMPTON HOSPITAL   (United Kingdom)

Author keywords

Clinical reasoning; Diagnosis; Guidelines; Idiopathic pulmonary fibrosis

Indexed keywords

COMORBIDITY; DIAGNOSTIC REASONING; DISEASE COURSE; DISEASE SEVERITY; EVIDENCE BASED MEDICINE; FIBROSING ALVEOLITIS; HIGH RESOLUTION COMPUTER TOMOGRAPHY; HISTOLOGY; HUMAN; INTERSTITIAL PNEUMONIA; LUNG BIOPSY; LUNG LAVAGE; MORTALITY RATE; NON INVASIVE MEASUREMENT; NOTE; ONSET AGE; PATIENT ATTITUDE; PATIENT SATISFACTION; PRACTICE GUIDELINE; BIOPSY; IDIOPATHIC PULMONARY FIBROSIS; MEDICAL SOCIETY; ORGANIZATION AND MANAGEMENT; PATHOLOGY; PROGNOSIS; STANDARDS; X-RAY COMPUTED TOMOGRAPHY;

BIOPSY; BRONCHOALVEOLAR LAVAGE; DISEASE PROGRESSION; HUMANS; IDIOPATHIC PULMONARY FIBROSIS; PRACTICE GUIDELINES AS TOPIC; PROGNOSIS; SOCIETIES, MEDICAL; TOMOGRAPHY, X-RAY COMPUTED;

EID: 84957571970     PISSN: None     EISSN: 17417015     Source Type: Journal    
DOI: 10.1186/s12916-016-0562-1     Document Type: Note

References (8)

1. Selman M, King Jr TE, Pardo A. Idiopathic pulmonary fibrosis: prevailing and evolving hypotheses about its pathogenesis and implications for therapy. Ann Intern Med. 2001;134:136-51.
2. Raghu G, Collard HR, Egan JJ, Martinez FJ, Behr J, Brown KK, et al. ATS/ERS/JRS/ALAT Committee on Idiopathic Pulmonary Fibrosis. An official ATS/ERS/JRS/ALAT statement: idiopathic pulmonary fibrosis: evidence-based guidelines for diagnosis and management. Am J Respir Crit Care Med. 2011;183:788-824.
3. Lettieri CJ, Veerappan GR, Helman DL, Mulligan CR, Shorr AF. Outcomes and safety of surgical lung biopsy for interstitial lung disease. Chest. 2005;127(5):1600-5.
4. Park JH, Kim DK, Kim DS, Koh Y, Lee S, Kim WS, et al. Mortality and risk factors for surgical lung biopsy in patients with idiopathic pulmonary fibrosis. Eur J Cardiothorac Surg. 2007;31:1115-9.
5. Casoni GL, Tomassetti S, Cavazza A, Colby TV, Dubini A, Ryu JH, et al. Cryobiopsy in the diagnosis of fibrotic interstitial lung diseases. PLoS One. 2014;9(2), e86716. doi: 10.1371/journal.pone.0086716.eCollection2014.
6. Demedts M, Behr J, Buhl R, Costabel U, Dekhuijzen R, Jansen HM, et al. IFIGENIA Study Group. High-dose acetylcysteine in idiopathic pulmonary fibrosis. N Engl J Med. 2005;353:2229-42.
7. Idiopathic Pulmonary Fibrosis Clinical Research Network, Raghu G, Anstrom KJ, King Jr TE, Lasky JA, Martinez FJ. Prednisone, azathioprine, and N-acetylcysteine for pulmonary fibrosis. N Engl J Med. 2012;366:1968-77.
8. Greenhalgh T, Howick J, Maskrey N. Evidence Based Medicine Renaissance Group. Evidence based medicine: a movement in crisis? BMJ. 2014;348:g3725. doi: 10.1136/bmj.g3725.